Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial
2021 · EBioMedicine · 116 citations
https://doi.org/10.1016/j.ebiom.2021.103789
R
Ruonan Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
117
Papers
4.7K
Citations
31
h-index
56
i10-index
Ruonan Xu is an academic researcher from Northwestern Polytechnical University. The author has contributed to research in topics: Immune Cell Function and Interaction & HIV Research and Treatment & T-cell and B-cell Immunology. The author has an h-index of 31, co-authored 100 publications.
ORCID: 0000-0002-4180-7754Papers by this author
worksLow expression of CXCR1/2 on neutrophils predicts poor survival in patients with hepatitis B virus-related acute-on-chronic liver failure
2016 · Scientific Reports · 35 citations
https://doi.org/10.1038/srep38714
Regulation of IL-8 production by complement-activated product, C5a, in vitro and in vivo during sepsis
2010 · Clinical Immunology · 33 citations
https://doi.org/10.1016/j.clim.2010.05.012
Adipocyte p53 coordinates the response to intermittent fasting by regulating adipose tissue immune cell landscape
2024 · Nature Communications · 27 citations
https://doi.org/10.1038/s41467-024-45724-y
Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis B
2023 · Hepatology International · 8 citations
https://doi.org/10.1007/s12072-023-10490-4
HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patients
2021 · Signal Transduction and Targeted Therapy · 5 citations
https://doi.org/10.1038/s41392-021-00550-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat